Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Kuipers, B; van den Dobbelsteen, G; Wedege, E; van Alphen, L
   Serological characterization
   MENINGOCOCCAL DISEASE
   
   B. Kuipers et al., "Serological characterization", METH MOL M, 67, 2001, pp. 131-145
2. Wedege, E
   Immunoblot analysis of sera from patients and vaccinees
   MENINGOCOCCAL VACCINES
   
   E. Wedege, "Immunoblot analysis of sera from patients and vaccinees", METH MOL M, 66, 2001, pp. 275-288
3. Jelfs, J; Munro, R; Wedege, E; Caugant, DA
   Sequence variation in the porA gene of a clone of Neisseria meningitidis during epidemic spread
   CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
   
   J. Jelfs et al., "Sequence variation in the porA gene of a clone of Neisseria meningitidis during epidemic spread", CL DIAG LAB, 7(3), 2000, pp. 390-395
4. Selander, B; Kayhty, H; Wedege, E; Holmstrom, E; Truedsson, L; Soderstrom, C; Sjoholm, AG
   Vaccination responses to capsular polysaccharides of Neisseria meningitidis and Haemophilus influenzae type b in two C2-deficient sisters: Alternative pathway-mediated bacterial killing and evidence for a novel type of blocking IgG
   JOURNAL OF CLINICAL IMMUNOLOGY
   
   B. Selander et al., "Vaccination responses to capsular polysaccharides of Neisseria meningitidis and Haemophilus influenzae type b in two C2-deficient sisters: Alternative pathway-mediated bacterial killing and evidence for a novel type of blocking IgG", J CLIN IMM, 20(2), 2000, pp. 138-149
5. Berstad, AKH; Andersen, SR; Dalseg, R; Dromtorp, S; Holst, J; Namork, E; Wedege, E; Haneberg, B
   Inactivated meningococci and pertussis bacteria are immunogenic and act asmucosal adjuvants for a nasal inactivated influenza virus vaccine
   VACCINE
   
   A.K.H. Berstad et al., "Inactivated meningococci and pertussis bacteria are immunogenic and act asmucosal adjuvants for a nasal inactivated influenza virus vaccine", VACCINE, 18(18), 2000, pp. 1910-1919
6. Berstad, AKH; Holst, J; Froholm, LO; Haugen, IL; Wedege, E; Oftung, F; Haneberg, B
   A nasal whole-cell pertussis vaccine induces specific: systemic and cross-reactive mucosal antibody responses in human volunteers
   JOURNAL OF MEDICAL MICROBIOLOGY
   
   A.K.H. Berstad et al., "A nasal whole-cell pertussis vaccine induces specific: systemic and cross-reactive mucosal antibody responses in human volunteers", J MED MICRO, 49(2), 2000, pp. 157-163
7. Wedege, E; Bolstad, K; Wetzler, LM; Guttormsen, HK
   IgG antibody levels to meningococcal porins in patient sera: comparison ofimmunoblotting and ELISA measurements
   JOURNAL OF IMMUNOLOGICAL METHODS
   
   E. Wedege et al., "IgG antibody levels to meningococcal porins in patient sera: comparison ofimmunoblotting and ELISA measurements", J IMMUNOL M, 244(1-2), 2000, pp. 9-15
8. Wedege, E; Caugant, DA; Musacchio, A; Saunders, NB; Zollinger, WD
   Redesignation of a purported P1.15 subtype-specific meningococcal monoclonal antibody as a P1.19-specific reagent
   CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
   
   E. Wedege et al., "Redesignation of a purported P1.15 subtype-specific meningococcal monoclonal antibody as a P1.19-specific reagent", CL DIAG LAB, 6(4), 1999, pp. 639-642
9. Toropainen, M; Kayhty, H; Saarinen, L; Rosenqvist, E; Hoiby, EA; Wedege, E; Michaelsen, T; Makela, PH
   The infant rat model adapted to evaluate human sera for protective immunity to group B meningococci
   VACCINE
   
   M. Toropainen et al., "The infant rat model adapted to evaluate human sera for protective immunity to group B meningococci", VACCINE, 17(20-21), 1999, pp. 2677-2689
10. Dalseg, R; Wedege, E; Holst, J; Haugen, IL; Hoiby, EA; Haneberg, B
    Outer membrane vesicles from group B meningococci are strongly immunogenicwhen given intranasally to mice
    VACCINE
    
    R. Dalseg et al., "Outer membrane vesicles from group B meningococci are strongly immunogenicwhen given intranasally to mice", VACCINE, 17(19), 1999, pp. 2336-2345
11. Wedege, E; Nokleby, H; Bjune, G
    No evidence for serosubtype-restricted protection among teenagers vaccinated with the Norwegian group B outer membrane vesicle vaccine
    JOURNAL OF INFECTIOUS DISEASES
    
    E. Wedege et al., "No evidence for serosubtype-restricted protection among teenagers vaccinated with the Norwegian group B outer membrane vesicle vaccine", J INFEC DIS, 180(1), 1999, pp. 242-242
12. Rosenqvist, E; Musacchio, A; Aase, A; Hoiby, EA; Namork, E; Kolberg, J; Wedege, E; Delvig, A; Dalseg, R; Michaelsen, TE; Tommassen, J
    Functional activities and epitope specificity of human and murine antibodies against the class 4 outer membrane protein (Rmp) of Neisseria meningitidis
    INFECTION AND IMMUNITY
    
    E. Rosenqvist et al., "Functional activities and epitope specificity of human and murine antibodies against the class 4 outer membrane protein (Rmp) of Neisseria meningitidis", INFEC IMMUN, 67(3), 1999, pp. 1267-1276
13. WEDEGE E; HOIBY EA; ROSENQVIST E; BJUNE G
    IMMUNE-RESPONSES AGAINST MAJOR OUTER-MEMBRANE ANTIGENS OF NEISSERIA-MENINGITIDIS IN VACCINEES AND CONTROLS WHO CONTRACTED MENINGOCOCCAL DISEASE DURING THE NORWEGIAN SEROGROUP-B PROTECTION TRIAL
    Infection and immunity
    
    E. Wedege et al., "IMMUNE-RESPONSES AGAINST MAJOR OUTER-MEMBRANE ANTIGENS OF NEISSERIA-MENINGITIDIS IN VACCINEES AND CONTROLS WHO CONTRACTED MENINGOCOCCAL DISEASE DURING THE NORWEGIAN SEROGROUP-B PROTECTION TRIAL", Infection and immunity, 66(7), 1998, pp. 3223-3231
14. HANEBERG B; DALSEG R; WEDEGE E; HOIBY EA; HAUGEN IL; OFTUNG F; ANDERSEN SR; NAESS LM; AASE A; MICHAELSEN TE; HOLST J
    INTRANASAL ADMINISTRATION OF A MENINGOCOCCAL OUTER-MEMBRANE VESICLE VACCINE INDUCES PERSISTENT LOCAL MUCOSAL ANTIBODIES AND SERUM ANTIBODIES WITH STRONG BACTERICIDAL ACTIVITY IN HUMANS
    Infection and immunity
    
    B. Haneberg et al., "INTRANASAL ADMINISTRATION OF A MENINGOCOCCAL OUTER-MEMBRANE VESICLE VACCINE INDUCES PERSISTENT LOCAL MUCOSAL ANTIBODIES AND SERUM ANTIBODIES WITH STRONG BACTERICIDAL ACTIVITY IN HUMANS", Infection and immunity, 66(4), 1998, pp. 1334-1341
15. DELVIG AA; WEDEGE E; MICHAELSEN TE; HOIBY EA; BRANDTZAEG P; ROSENQVIST E
    IMMUNE-RESPONSES TO LINEAR EPITOPES ON THE PORB PROTEIN OF NEISSERIA-MENINGITIDIS IN PATIENTS WITH SYSTEMIC MENINGOCOCCAL DISEASE
    Microbiology
    
    A.A. Delvig et al., "IMMUNE-RESPONSES TO LINEAR EPITOPES ON THE PORB PROTEIN OF NEISSERIA-MENINGITIDIS IN PATIENTS WITH SYSTEMIC MENINGOCOCCAL DISEASE", Microbiology, 142, 1996, pp. 2491-2498
16. DELVIG AA; WEDEGE E; CAUGANT DA; DALSEG R; KOLBERG J; ACHTMAN M; ROSENQVIST E
    A LINEAR B-CELL EPITOPE AN THE CLASS-3 OUTER-MEMBRANE PROTEIN OF NEISSERIA-MENINGITIDIS RECOGNIZED AFTER VACCINATION WITH THE NORWEGIAN GROUP-B OUTER-MEMBRANE VESICLE VACCINE
    Microbiology
    
    A.A. Delvig et al., "A LINEAR B-CELL EPITOPE AN THE CLASS-3 OUTER-MEMBRANE PROTEIN OF NEISSERIA-MENINGITIDIS RECOGNIZED AFTER VACCINATION WITH THE NORWEGIAN GROUP-B OUTER-MEMBRANE VESICLE VACCINE", Microbiology, 141, 1995, pp. 1593-1600
17. WEDEGE E; KOLBERG J; DELVIG A; HOIBY EA; HOLTEN E; ROSENQVIST E; CAUGANT DA
    EMERGENCE OF A NEW VIRULENT CLONE WITHIN THE ELECTROPHORETIC TYPE 5 COMPLEX OF SEROGROUP-B MENINGOCOCCI IN NORWAY
    Clinical and diagnostic laboratory immunology
    
    E. Wedege et al., "EMERGENCE OF A NEW VIRULENT CLONE WITHIN THE ELECTROPHORETIC TYPE 5 COMPLEX OF SEROGROUP-B MENINGOCOCCI IN NORWAY", Clinical and diagnostic laboratory immunology, 2(3), 1995, pp. 314-321
18. IDANPAANHEIKKILA I; HOIBY EA; CHATTOPADHYAY P; AIRAKSINEN U; MICHAELSEN TM; WEDEGE E
    ANTIBODIES TO MENINGOCOCCAL CLASS-1 OUTER-MEMBRANE PROTEIN AND ITS VARIABLE REGIONS IN PATIENTS WITH SYSTEMIC MENINGOCOCCAL DISEASE
    Journal of Medical Microbiology
    
    I. Idanpaanheikkila et al., "ANTIBODIES TO MENINGOCOCCAL CLASS-1 OUTER-MEMBRANE PROTEIN AND ITS VARIABLE REGIONS IN PATIENTS WITH SYSTEMIC MENINGOCOCCAL DISEASE", Journal of Medical Microbiology, 43(5), 1995, pp. 335-343
19. ROSENQVIST E; HOIBY EA; WEDEGE E; BRYN K; KOLBERG J; KLEM A; RONNILD E; BJUNE G; NOKLEBY H
    HUMAN-ANTIBODY RESPONSES TO MENINGOCOCCAL OUTER-MEMBRANE ANTIGENS AFTER 3 DOSES OF THE NORWEGIAN GROUP-B MENINGOCOCCAL VACCINE
    Infection and immunity
    
    E. Rosenqvist et al., "HUMAN-ANTIBODY RESPONSES TO MENINGOCOCCAL OUTER-MEMBRANE ANTIGENS AFTER 3 DOSES OF THE NORWEGIAN GROUP-B MENINGOCOCCAL VACCINE", Infection and immunity, 63(12), 1995, pp. 4642-4652
20. CAUGANT DA; HOIBY EA; MAGNUS P; SCHEEL O; HOEL T; BJUNE G; WEDEGE E; ENG J; FROHOLM LO
    ASYMPTOMATIC CARRIAGE OF NEISSERIA-MENINGITIDIS IN A RANDOMLY SAMPLEDPOPULATION
    Journal of clinical microbiology
    
    D.A. Caugant et al., "ASYMPTOMATIC CARRIAGE OF NEISSERIA-MENINGITIDIS IN A RANDOMLY SAMPLEDPOPULATION", Journal of clinical microbiology, 32(2), 1994, pp. 323-330
21. ROSENQVIST E; HOIBY EA; WEDEGE E; CAUGANT DA; FROHOLM LO; MCGUINNESS BT; BROOKS J; LAMBDEN PR; HECKELS JE
    A NEW VARIANT OF SEROSUBTYPE P1.16 IN NEISSERIA-MENINGITIDIS FROM NORWAY, ASSOCIATED WITH INCREASED RESISTANCE TO BACTERICIDAL ANTIBODIES INDUCED BY A SEROGROUP-B OUTER-MEMBRANE PROTEIN VACCINE
    Microbial pathogenesis
    
    E. Rosenqvist et al., "A NEW VARIANT OF SEROSUBTYPE P1.16 IN NEISSERIA-MENINGITIDIS FROM NORWAY, ASSOCIATED WITH INCREASED RESISTANCE TO BACTERICIDAL ANTIBODIES INDUCED BY A SEROGROUP-B OUTER-MEMBRANE PROTEIN VACCINE", Microbial pathogenesis, 15(3), 1993, pp. 197-205
22. ROSENQVIST E; HOIBY EA; WEDEGE E; KUSECEK B; ACHTMAN M
    THE 5C PROTEIN OF NEISSERIA-MENINGITIDIS IS HIGHLY IMMUNOGENIC IN HUMANS AND INDUCES BACTERICIDAL ANTIBODIES
    The Journal of infectious diseases
    
    E. Rosenqvist et al., "THE 5C PROTEIN OF NEISSERIA-MENINGITIDIS IS HIGHLY IMMUNOGENIC IN HUMANS AND INDUCES BACTERICIDAL ANTIBODIES", The Journal of infectious diseases, 167(5), 1993, pp. 1065-1073